Paroxysmal AV block other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}}{{Akash}}
{{CMG}}; {{AE}}{{Akash}}
==Overview==
==Overview==
There are no other diagnostic studies associated with [disease name].
An [[Implantable Cardiac Monitor]] is almost exclusively used in the [[diagnosis]] of [[bradycardia]] related disorders such as high-grade [[atrioventricular block]], [[sinus node dysfunction]] and [[neurocardiogenic syncope]] (with predominant cardio-inhibitory component). This prolonged monitoring (up to 3 years) can help correlate [[bradycardia]] conduction disorders with symptoms. An [[EPS]] is an invasive [[catheter]] based procedure that is employed to detect and [[anatomically]] locate conduction disorders. An increased [[HH interval]] is seen in [[intrinsic paroxysmal AV Block]]. Certain maneuvers cause an increase in [[vagal]] surge and may precipitate symptoms in extrinsic vagal paroxysmal AV block. These include [[carotid sinus massage]] and [[tilt table testing]].  


OR
==Implantable Loop Recorder==
*[[Implantable loop recorders]] are useful tools as they help correlate electrical tracings with the patients [[symptoms]] during an [[acute]] event.
**By giving an inkling of the [[etiology]] of the [[syncope]], it helps guide [[therapy]] strategies, such as adopting permanent stimulation devices in patients with [[paroxysmal AV block]].<ref name="pmid28496928">{{cite journal| author=Guerrero-Márquez FJ, Arana-Rueda E, Pedrote A| title=Idiopathic Paroxysmal Atrio-Ventricular Block. What is The Mechanism? | journal=J Atr Fibrillation | year= 2016 | volume= 9 | issue= 3 | pages= 1449 | pmid=28496928 | doi=10.4022/jafib.1449 | pmc=5368548 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28496928  }} </ref>
* According to the '''European Society of Cardiology''', the indication for [[implantable loop recorders]] are as follows :
*#In the early phase of evaluation in patients with recurrent [[syncope]] of uncertain origin, absence of high risk criteria and a high likelihood of recurrence within the battery life of the device
*#In patients with suspected or certain [[reflex syncope]] presenting with frequent or severe [[Syncope|syncopal]] episodes
*#In patients whom [[epilepsy]] was suspected but the treatment has proven ineffective.
*#In patients with unexplained falls. {{cite web |url=https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Syncope-Guidelines-on-Diagnosis-and-Management-of |title=ESC Guidelines on Syncope (Diagnosis and Management of) |format= |work= |accessdate=}}


[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
*'''The ISSUE (International Study on Syncope of Unknown Etiology)''' study conducted by '''Brignole et a'''l monitored 198 patients with an [[implantable loop recorder]] and classified the first syncope event following implantation.
**The ISSUE classification has '''[[pathophysiological]] implications''' in terms of the event being [[neutrally mediated]] (type 1A or type 1B or type 2), due to an intrinsic [[Conduction System|conduction]] defect (type 1C), secondary to [[Orthostatic hypotension|orthostatic hypotension (]]<nowiki/>type 4A) or a primary [[cardiac]] [[Cardiac arrhythmia|arrhythmia]] (types 4B, 4C or 4D).<ref name="pmid15670961">{{cite journal| author=Brignole M, Moya A, Menozzi C, Garcia-Civera R, Sutton R| title=Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder. | journal=Europace | year= 2005 | volume= 7 | issue= 1 | pages= 14-8 | pmid=15670961 | doi=10.1016/j.eupc.2004.11.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15670961  }} </ref>


OR
[[Image:ISSUE Classification.JPG|thumb|center|500px|ISSUE ECG Classification-{{cite web |url=https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Syncope-Guidelines-on-Diagnosis-and-Management-of |title=ESC Guidelines on Syncope (Diagnosis and Management of) |format= |work= |accessdate=}}]]


Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
*'''The ISSUE 2 study''' (characterized by a frequently injured [[elderly]] population with a history of recurrent [[syncope]]) demonstrated the importance o[[Implantable loop recorders|f implantable loop recorders]] (ILR) as a [[Diagnosis|diagnostic]] modality by showing that '''the recurrence rate in [[syncope]] patients treated with ILR based therapy was much lower than those treated with no-specific therapy'''.
**In addition, a recurrence rate of 5% was noted in those treated with [[cardiac pacing]].<ref name="pmid16569653">{{cite journal| author=Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W | display-authors=etal| title=Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. | journal=Eur Heart J | year= 2006 | volume= 27 | issue= 9 | pages= 1085-92 | pmid=16569653 | doi=10.1093/eurheartj/ehi842 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16569653  }} </ref>


==Other Diagnostic Studies==
=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay:Recommendation for Implantable Cardiac Monitor=


There are no other diagnostic studies associated with [disease name].
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Pink"|[[2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay| Recommendation for Implantable Cardiac Monitor]]
|-
| bgcolor="Pink"|<nowiki>"</nowiki>'''1.''' In patients with infrequent symptoms (>30 days between symptoms) suspected to be caused by bradycardia, longterm ambulatory monitoring with an implantable cardiac monitor (ICM) is reasonable if initial noninvasive evaluation is nondiagnostic.''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki>
|}


OR
*An Implantable Cardiac Monitor is almost exclusively used in the diagnosis of [[bradycardia]] related disorders such as high-grade [[atrioventricular block]], [[sinus node dysfunction]] and [[neurocardiogenic syncope]] (with a predominant cardio-inhibitory component).
*This prolonged monitoring (up to 3 years) can help correlate [[bradycardia]] [[Conduction System|conduction]] disorders with [[Symptom|symptoms]]<ref name="pmid30412710">{{cite journal| author=Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR | display-authors=etal| title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2019 | volume= 74 | issue= 7 | pages= 932-987 | pmid=30412710 | doi=10.1016/j.jacc.2018.10.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30412710  }} </ref>.


[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include:
==Electrophysiologic studies (EPS)==
*[Finding 1]
*The decision to perform an EPS requires a '''global risk assessment'''.
*[Finding 2]
**The application of this study is most important in diagnosing '''I-AVB'''.
*[Finding 3]
*According to the '''European Society of Cardiology''', indications for EPS are as follows :
*# In patients with [[syncope]] and previous [[myocardial infarction]] or other scar related conditions, EPS is indicated when [[syncope]] remains unexplained after non- invasive evaluation.
*#In patients with [[syncope]] and asymptomatic [[sinus bradycardia]], EPS may be considered in a few instances where no invasive tests (eg. ECG monitoring) have failed to show a correlation between [[syncope]] and [[bradycardia]].
*#In patients with [[syncope]] preceded by sudden and brief [[palpitations]], EPS may be considered when [[syncope]] remains unexplained after non invasive evaluation. {{cite web |url=https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Syncope-Guidelines-on-Diagnosis-and-Management-of |title=ESC Guidelines on Syncope (Diagnosis and Management of) |format= |work= |accessdate=}}


OR
====EPS guided therapy====


Other diagnostic studies for [disease name] include:
*#In patients with unexplained [[syncope]] and bifasicular [[bundle branch block]], a [[pacemaker]] is indicated in the presence of either a baseline H-V interval of more than or equal to 70ms, or second or third degree [[His- Purkinje]] block during incremental atrial [[pacing]], or with pharmacological challenge.
*[Diagnostic study 1], which demonstrates:
*# In patients with unexplained [[syncope]] and previous [[myocardial infarction]] or scar related condition, it is recommended to manage induction of sustained [[monomorphic ventricular tachycardia]] according to the current European Society of Cardiology Guidelines for [[Ventricular Arrhythmias]].
**[Finding 1]
*#In patients without structural heart disease with [[syncope]] preceded by sudden and brief [[palpitations]], it is recommended to manage the induction of rapid [[SVT]] or [[Ventricular tachycardia|VT]], which reproduces [[Hypotension|hypotensive]] or spontaneous symptoms, with appropriate therapy according to the current European Society of Cardiology Guidelines.
**[Finding 2]
*#In patients with [[syncope]] and [[asymptomatic]] [[sinus bradycardia]], a [[pacemaker]] should be considered is a prolonged [[sinus node]] recovery time is present.{{cite web |url=https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Syncope-Guidelines-on-Diagnosis-and-Management-of |title=ESC Guidelines on Syncope (Diagnosis and Management of) |format= |work= |accessdate=}}
**[Finding 3]
 
*[Diagnostic study 2], which demonstrates:  
*'''A 42 month follow up was performed by Gronda et al in 155 patients''', majority of whom had a history of previous syncope.
**[Finding 1]
**[[Electrophysiologic study]] findings of '''basal HV greater than or equal to 65 ms , HV value greater than or equal to 120 ms or 2nd-3rd degree atrioventricular block during ajmaline test and HV prolonged greater than 10 ms or 2nd-3rd degree [[atrioventricular block]] during atrial [[pacing]] correlated to an increased risk of developing advanced [[atrioventricular block]] below the [[AV node]]'''.<ref name="pmid6519386">{{cite journal| author=Gronda M, Magnani A, Occhetta E, Sauro G, D'Aulerio M, Carfora A | display-authors=etal| title=Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. | journal=G Ital Cardiol | year= 1984 | volume= 14 | issue= 10 | pages= 768-73 | pmid=6519386 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6519386  }} </ref>
**[Finding 2]
 
**[Finding 3]
[[Image:Diagnostic Summary 2.JPG|thumb|center|500px|EPS significance-{{cite web |url=https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.joa.2017.03.008 |title=Syncope and paroxysmal atrioventricular block - Aste - 2017 - Journal of Arrhythmia - Wiley Online Library |format= |work= |accessdate=}}]]
 
=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay=
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Lightgreen"|[[2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay| Recommendation for Electrophysiology Testing]]
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''  In patients with symptoms suspected to be attributable to bradycardia, an electrophysiology study (EPS) may be considered in selected patients for diagnosis of, and elucidation of bradycardia mechanism, if initial noninvasive evaluation is nondiagnostic''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C-LD]])<ref name="pmid30412710">{{cite journal| author=Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR | display-authors=etal| title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2019 | volume= 74 | issue= 7 | pages= 932-987 | pmid=30412710 | doi=10.1016/j.jacc.2018.10.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30412710  }} </ref>''<nowiki>"</nowiki>
|}
 
*An EPS is an invasive [[catheter]] based procedure that is employed to detect and [[Anatomy|anatomically]] locate [[Conduction System|conduction]] disorders.
*It is well tolerated, has a low [[Complications|complication]] risk and not usually employed as a first line study in the diagnosis of [[bradycardia]] related disorders. <ref name="pmid30412710">{{cite journal| author=Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR | display-authors=etal| title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2019 | volume= 74 | issue= 7 | pages= 932-987 | pmid=30412710 | doi=10.1016/j.jacc.2018.10.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30412710  }} </ref>
 
==Vagal Maneuvers : Carotid Sinus massage and Tilt Table testing==
*Though not specific,[[tilt table testing]] (TT) and other [[vagal]] maneuvers such as the [[vasalva]] maneuver, eye ball pressure and immersing one's face in cold water can be used in the diagnosis of '''EV-AVB'''.
*'''The Syncope Unit Project-2 study''' found an increase recurrence rate in patients who did not undergo tilt table testing. This highlights '''the utility of TT as a screening test for reflex syncope'''.<ref name="pmid26612880">{{cite journal| author=Brignole M, Arabia F, Ammirati F, Tomaino M, Quartieri F, Rafanelli M | display-authors=etal| title=Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study. | journal=Europace | year= 2016 | volume= 18 | issue= 9 | pages= 1427-33 | pmid=26612880 | doi=10.1093/europace/euv343 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26612880  }} </ref>
*A positive response is indicated as a '''marker of [[hypotensive]] susceptibility which involves a decrease in both [[Preload (cardiology)|preload]] and [[afterload]]'''.
*Having said that, a negative test '''does not rule out the possibility of an [[extrinsic vagal paroxysmal AV block]]'''.
*A [[carotid sinus massage]] is indicated in '''patients more than 40 years of age with [[syncope]] of unknown origin compatible with [[reflex]] mechanism'''.
**[[Carotid sinus]] sensitivity is confirmed if [[carotid sinus massage]] causes [[bradycardia]] ([[asystole]]) and/or [[hypotension]] that reproduce spontaneous symptoms and patients have clinical features compatible with [[reflex]] mechanism of [[syncope]]. {{cite web |url=https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Syncope-Guidelines-on-Diagnosis-and-Management-of |title=ESC Guidelines on Syncope (Diagnosis and Management of) |format= |work= |accessdate=}}
 
[[Image:Carotid Sinus Massage.JPG|thumb|center|500px|Carotid Sinus Massage- {{cite web |url=https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Syncope-Guidelines-on-Diagnosis-and-Management-of |title=ESC Guidelines on Syncope (Diagnosis and Management of) |format= |work= |accessdate=}}]]


==References==
==References==

Latest revision as of 06:28, 11 July 2020

Paroxysmal AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paroxysmal AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paroxysmal AV block other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paroxysmal AV block other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paroxysmal AV block other diagnostic studies

CDC on Paroxysmal AV block other diagnostic studies

Paroxysmal AV block other diagnostic studies in the news

Blogs on Paroxysmal AV block other diagnostic studies

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Paroxysmal AV block other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

An Implantable Cardiac Monitor is almost exclusively used in the diagnosis of bradycardia related disorders such as high-grade atrioventricular block, sinus node dysfunction and neurocardiogenic syncope (with predominant cardio-inhibitory component). This prolonged monitoring (up to 3 years) can help correlate bradycardia conduction disorders with symptoms. An EPS is an invasive catheter based procedure that is employed to detect and anatomically locate conduction disorders. An increased HH interval is seen in intrinsic paroxysmal AV Block. Certain maneuvers cause an increase in vagal surge and may precipitate symptoms in extrinsic vagal paroxysmal AV block. These include carotid sinus massage and tilt table testing.

Implantable Loop Recorder

  • Implantable loop recorders are useful tools as they help correlate electrical tracings with the patients symptoms during an acute event.
  • According to the European Society of Cardiology, the indication for implantable loop recorders are as follows :
    1. In the early phase of evaluation in patients with recurrent syncope of uncertain origin, absence of high risk criteria and a high likelihood of recurrence within the battery life of the device
    2. In patients with suspected or certain reflex syncope presenting with frequent or severe syncopal episodes
    3. In patients whom epilepsy was suspected but the treatment has proven ineffective.
    4. In patients with unexplained falls. "ESC Guidelines on Syncope (Diagnosis and Management of)".
ISSUE ECG Classification-"ESC Guidelines on Syncope (Diagnosis and Management of)".
  • The ISSUE 2 study (characterized by a frequently injured elderly population with a history of recurrent syncope) demonstrated the importance of implantable loop recorders (ILR) as a diagnostic modality by showing that the recurrence rate in syncope patients treated with ILR based therapy was much lower than those treated with no-specific therapy.
    • In addition, a recurrence rate of 5% was noted in those treated with cardiac pacing.[3]

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay:Recommendation for Implantable Cardiac Monitor

Recommendation for Implantable Cardiac Monitor
"1. In patients with infrequent symptoms (>30 days between symptoms) suspected to be caused by bradycardia, longterm ambulatory monitoring with an implantable cardiac monitor (ICM) is reasonable if initial noninvasive evaluation is nondiagnostic.(Level of Evidence: C-LD) "

Electrophysiologic studies (EPS)

  • The decision to perform an EPS requires a global risk assessment.
    • The application of this study is most important in diagnosing I-AVB.
  • According to the European Society of Cardiology, indications for EPS are as follows :
    1. In patients with syncope and previous myocardial infarction or other scar related conditions, EPS is indicated when syncope remains unexplained after non- invasive evaluation.
    2. In patients with syncope and asymptomatic sinus bradycardia, EPS may be considered in a few instances where no invasive tests (eg. ECG monitoring) have failed to show a correlation between syncope and bradycardia.
    3. In patients with syncope preceded by sudden and brief palpitations, EPS may be considered when syncope remains unexplained after non invasive evaluation. "ESC Guidelines on Syncope (Diagnosis and Management of)".

EPS guided therapy

  • A 42 month follow up was performed by Gronda et al in 155 patients, majority of whom had a history of previous syncope.
EPS significance-"Syncope and paroxysmal atrioventricular block - Aste - 2017 - Journal of Arrhythmia - Wiley Online Library".

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

Recommendation for Electrophysiology Testing
"1. In patients with symptoms suspected to be attributable to bradycardia, an electrophysiology study (EPS) may be considered in selected patients for diagnosis of, and elucidation of bradycardia mechanism, if initial noninvasive evaluation is nondiagnostic(Level of Evidence: C-LD)[4]"

Vagal Maneuvers : Carotid Sinus massage and Tilt Table testing

Carotid Sinus Massage- "ESC Guidelines on Syncope (Diagnosis and Management of)".

References

  1. ↑ Guerrero-Márquez FJ, Arana-Rueda E, Pedrote A (2016). "Idiopathic Paroxysmal Atrio-Ventricular Block. What is The Mechanism?". J Atr Fibrillation. 9 (3): 1449. doi:10.4022/jafib.1449. PMC 5368548. PMID 28496928.
  2. ↑ Brignole M, Moya A, Menozzi C, Garcia-Civera R, Sutton R (2005). "Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder". Europace. 7 (1): 14–8. doi:10.1016/j.eupc.2004.11.001. PMID 15670961.
  3. ↑ Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W; et al. (2006). "Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope". Eur Heart J. 27 (9): 1085–92. doi:10.1093/eurheartj/ehi842. PMID 16569653.
  4. ↑ 4.0 4.1 4.2 Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR; et al. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society". J Am Coll Cardiol. 74 (7): 932–987. doi:10.1016/j.jacc.2018.10.043. PMID 30412710.
  5. ↑ Gronda M, Magnani A, Occhetta E, Sauro G, D'Aulerio M, Carfora A; et al. (1984). "Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications". G Ital Cardiol. 14 (10): 768–73. PMID 6519386.
  6. ↑ Brignole M, Arabia F, Ammirati F, Tomaino M, Quartieri F, Rafanelli M; et al. (2016). "Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study". Europace. 18 (9): 1427–33. doi:10.1093/europace/euv343. PMID 26612880.


Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Paroxysmal_AV_block_other_diagnostic_studies&oldid=1624280"